Business Overview

Ginzton Technology Center
 

(Dollars in Millions)         2000    1999     1998
Net Orders                   $  18   $  12    $   5
Sales                        $  20   $   8    $   5
Pretax Losses-as Reported    $  (5)  $  (8)   $  (9)
Backlog                      $   8   $  10    $   6
Capital Expenditures         $   1   $   3    $   1
Depreciation & Amortization  $   2   $   1    $   1



The Ginzton Technology Center acts as Varian Medical Systems' research and development facility for breakthrough technologies and operates a growing brachytherapy business for the delivery of internal radiation to treat cancer and cardiovascular disease. In addition to brachytherapy, current efforts are focused on next-generation imaging systems and advanced targeting technologies for radiotherapy. The center is also investigating the combination of radiotherapy with other treatment modalities, such as bioengineered gene delivery systems.

Products + Services
Brachytherapy products:
  • VariSource™ high-dose rate brachytherapy delivery systems
  • VariSeed™ treatment planning software
  • BrachyVision™ treatment planning software

2000 Highlights
The Ginzton Technology Center increased sales of brachytherapy products by more than 200 percent over fiscal year 1999 totals. Two new products - the VariSource 200 Afterloader for high-dose rate brachytherapy and the BrachyVision 6.0 software - contributed to the higher sales. Production capacity for the VariSource product line tripled. Production commenced on a new longer-lasting and more flexible source wire for high-dose rate brachytherapy. The business formed an alliance with Cordis, a Johnson and Johnson Company, to supply and service radiation sources for cardiovascular brachytherapy.

Outlook
The global market for brachytherapy products should continue to grow, partly with the help of new cardiovascular applications and the desire for less invasive therapeutic options. Ginzton Technology Center will compete in this market with a broad line of devices and software, including some new products that should be introduced during the year. Research will remain focused on advancing targeting technology for radiotherapy as well as the use of biotechnology to enhance outcomes with radiotherapy.

Facilities

Charlottesville, Virginia

Crawley, England

Mountain View, California
(headquarters)